New Enterprise Associates has stepped up to back San Diego-based Tracon Pharmaceuticals, joining a syndicate that is betting $27 million on the company’s two cancer therapies, including a mid-stage drug now in the clinic for soft tissue sarcoma.

…read more

Source: NEA pitches in on a $27M gamble on Tracon’s mid-stage cancer drug program


0 No comments